As of Jan 20
| +0.145 / +0.40%|
The 24 analysts offering 12-month price forecasts for Merck KGaA have a median target of 37.99, with a high estimate of 44.13 and a low estimate of 32.51. The median estimate represents a +4.04% increase from the last price of 36.52.
The current consensus among 24 polled investment analysts is to Buy stock in Merck KGaA. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.